Cibc Private Wealth Group, LLC Veracyte, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 961 shares of VCYT stock, worth $39,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
961
Previous 675
42.37%
Holding current value
$39,919
Previous $14,000
128.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.6MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$324 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$322 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$209 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$204 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$176 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.97B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...